The Clorox Company (NYSE:CLX) Shares Sold by Pegasus Asset Management Inc.

Pegasus Asset Management Inc. cut its holdings in shares of The Clorox Company (NYSE:CLX) by 10.7% during the fourth quarter, HoldingsChannel.com reports. The fund owned 1,669 shares of the company’s stock after selling 200 shares during the period. Pegasus Asset Management Inc.’s holdings in Clorox were worth $271,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Mizuho Securities USA LLC raised its stake in shares of Clorox by 46,877.8% in the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock valued at $733,095,000 after acquiring an additional 4,490,421 shares during the period. Ilex Capital Partners UK LLP raised its stake in shares of Clorox by 512.7% in the 3rd quarter. Ilex Capital Partners UK LLP now owns 542,110 shares of the company’s stock valued at $88,315,000 after acquiring an additional 453,624 shares during the period. International Assets Investment Management LLC raised its stake in shares of Clorox by 424.9% in the 3rd quarter. International Assets Investment Management LLC now owns 538,576 shares of the company’s stock valued at $877,390,000 after acquiring an additional 435,971 shares during the period. Boston Trust Walden Corp grew its holdings in Clorox by 5,442.5% during the 3rd quarter. Boston Trust Walden Corp now owns 273,908 shares of the company’s stock worth $44,622,000 after acquiring an additional 268,966 shares in the last quarter. Finally, Assenagon Asset Management S.A. grew its holdings in Clorox by 302.0% during the 4th quarter. Assenagon Asset Management S.A. now owns 353,367 shares of the company’s stock worth $57,390,000 after acquiring an additional 265,455 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

CLX has been the subject of several analyst reports. DA Davidson lowered their price target on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a report on Wednesday, February 5th. Barclays boosted their price target on shares of Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a report on Wednesday, February 5th. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and upped their target price for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. StockNews.com cut shares of Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Finally, JPMorgan Chase & Co. upped their price target on shares of Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a research report on Tuesday, February 4th. Four research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat.com, Clorox currently has a consensus rating of “Hold” and a consensus target price of $158.21.

Clorox Trading Up 0.1 %

CLX opened at $148.11 on Wednesday. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The firm has a market capitalization of $18.33 billion, a P/E ratio of 40.47, a P/E/G ratio of 2.53 and a beta of 0.42. The firm’s 50 day moving average is $158.78 and its 200-day moving average is $159.71.

Clorox (NYSE:CLX) last released its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the prior year, the company earned $2.16 earnings per share. Analysts expect that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.